Why researchers are interested
Eating disorders are serious mental health conditions that can affect physical health, cognition, mood, and relationships. Anorexia nervosa, bulimia nervosa, and binge-eating disorder involve different symptoms and medical risks, and treatment must be individualized. Some patients experience persistent symptoms despite specialized care, prompting research into additional therapeutic approaches.
Psilocybin-assisted psychotherapy is one emerging area of investigation, particularly for anorexia nervosa. Researchers are exploring whether a supported psychedelic experience might influence rigid thought patterns, self-perception, and psychological flexibility. These are hypotheses under study, not established clinical benefits.
What early studies have shown
Early feasibility research has examined psilocybin administration in small groups of adults with anorexia nervosa. Such studies have helped researchers assess whether the intervention can be delivered under controlled conditions and have generated preliminary observations about participants’ experiences and symptoms.
Feasibility and open-label findings cannot establish that a treatment works. Without larger randomized comparisons, it is difficult to separate a drug-related effect from expectations, concurrent treatment, changes over time, or the intensive clinical support provided in the study. Research into other eating disorders is also at an earlier stage.
Why medical screening is especially important
Eating disorders can cause malnutrition, electrolyte abnormalities, changes in heart rhythm, low blood pressure, and other complications. These risks may be present even when someone appears outwardly healthy. Psilocybin can temporarily affect heart rate, blood pressure, perception, and emotional state, making careful medical assessment particularly important.
A responsible research program needs to evaluate nutritional and medical stability, psychiatric symptoms, medications, and the person’s capacity to participate safely. An investigational psychedelic intervention should not replace nutritional rehabilitation, medical monitoring, or specialized psychotherapy.
What researchers still need to learn
Important questions include whether psilocybin can improve eating-disorder symptoms beyond the effects of structured support, which patients might benefit, and whether any changes persist. Researchers also need to understand how the intervention interacts with body image distress, obsessive thinking, anxiety, and co-occurring depression.
Another concern is that a powerful subjective experience could be interpreted as a cure before behavior and physical health have meaningfully improved. Sustained recovery usually requires ongoing clinical work and careful attention to nutrition, medical risk, and daily functioning.
Finding appropriate care in California
Psilocybin-assisted treatment for eating disorders is investigational, not an FDA-approved standard service in California as of October 2026. Anyone experiencing significant restriction, purging, fainting, or other medical symptoms should seek appropriate clinical evaluation rather than wait for a psychedelic study.
For people who want to understand research opportunities, our psilocybin therapy in California and clinical trials guides explain how to assess programs and why eligibility criteria matter. Established eating-disorder treatment should remain the foundation of care while research continues.
Learn More About Psychedelic Therapy in California
Whether you’re exploring treatment options or looking for information specific to your region, continue your research with these guides.
Treatment Guides
- MDMA Therapy in California
- Psilocybin Therapy in California
- Ketamine Therapy
- Psychedelic Integration Therapy
- Psychedelic Clinical Trials California
Regional Guides
- Bay Area Psychedelic Therapy Guide
- Los Angeles Psychedelic Therapy Guide
- Orange County Psychedelic Therapy Guide
- San Diego Psychedelic Therapy Guide
- Sacramento Psychedelic Therapy Guide
- San Jose Psychedelic Therapy Guide
- Silicon Valley Psychedelic Therapy Guide
- Inland Empire Psychedelic Therapy Guide
- Central Coast Psychedelic Therapy Guide